相关实验视频
Updated: Jul 9, 2025

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
在淋巴瘤患者的治疗中采用综合方法
Ilana Levy Yurkovski1,2,3, Francesca Andreazzoli4, Eran Ben-Arye5,6
1Hematology Unit, Bnai Zion Medical Center, Golomb 47, 33394, Haifa, Israel. ilana.e.levy@gmail.com.
补充和整合医学 (CIM) 对淋巴瘤患者提供了潜在的好处,有助于预防,症状管理和预后. 在将CIM与传统疗法相结合时,仔细考虑安全性至关重要.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 综合医学是一个整体医学.
背景情况:
- 淋巴瘤是一种常见的血液性恶性瘤,具有不同的管理阶段.
- 患者在预防,缓解症状和预后方面面临着未满足的需求.
- 补充和整合医学 (CIM) 经常被淋巴瘤患者使用.
研究的目的:
- 审查用于淋巴瘤管理的有效和安全的CIM模式.
- 探索CIM在淋巴瘤治疗连续性中的作用.
主要方法:
- 对淋巴瘤的CIM干预措施的文献综述.
- 对有效性和安全性的证据的分析.
主要成果:
- 饮食干预和人参可能有助于预防.
- 针,触摸疗法和补充剂可以缓解疼痛,神经病变,恶心,疲劳和失眠.
- 维生素D,黄素和草药可以改善预后.
- 存在安全问题,特别是在同时使用补充剂和传统治疗时.
结论:
- 对于淋巴瘤患者来说,CIM模式在整个旅程中都很有前途.
- 整合CIM需要仔细注意与标准疗法的潜在相互作用.
更多相关视频
07:52Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
相关概念视频
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Tumor Microenvironment